Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rostafuroxin vs Losartan in Genetically Selected Hypertensive Patients
NCT01320397Phase 2Unknown
- Start
- May 2011
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of rostafuroxin in essential hypertension. Status: unknown.
02
Drugs
rostafuroxin
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01320397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320397.